Ottimedi SRL
Ottimedi reported total assets of 567,329 € at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Aug 2026).
The score of Ottimedi shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +98 % Total assets +63 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Ottimedi's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 137,800 € | ||||
| Equity | 420,994 € | ||||
| Cash | 306,045 € | ||||
| EBITDA | 214,919 € | ||||
| Total assets | 567,329 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Aug 2026
- Year ended 31 Dec 2024filed on 28 Aug 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 22 Nov 2022
Ottimedi's financial analysis
- Solvency74.2%sector median: 47.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Ottimedi
Ottimedi's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0474.978.910
- VAT number
- BE0474978910
- Peppol
- Registered · 0208:0474978910 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 18 Jun 2001
- Registered office
- 3052 Oud-Heverlee
- Latest accounts
- 2025 · filed on 29 Aug 2026
- Activity
- Retail sale of medical and orthopaedic goods, except corrective glasses, lenses and sunglasses (NACE 47741)
Ottimedi (SRL) has been based in Oud-Heverlee since 2001, active in: retail sale of medical and orthopaedic goods, except corrective glasses, lenses and sunglasses. For 2025, it reports a net profit of 137,800 € and equity of 420,994 €; its revenue is not published. Its solvency stands at 74.2%, above the median of its sector (47.4%).
Companies similar to Ottimedi
Companies in the same business, of comparable size and area, outside its group.
- Kourion.BE Retail sale of medical and orthopaedic goods Bertem · balance sheet 325,956 €
- Orthodesign Retail sale of medical and orthopaedic goods Herselt · balance sheet €1.68m
- Vimed Business and other management consultancy activities Brecht · balance sheet 278,478 €
- LUC Petit Medical Retail sale of medical and orthopaedic goods Esneux · balance sheet 614,504 €
- Laboratory Consulting & Services Retail sale of medical and orthopaedic goods Tournai · balance sheet 479,588 €
- Orthocam Retail sale of medical and orthopaedic goods Grobbendonk · balance sheet €1.09m
- Hooratelier Retail sale of medical and orthopaedic goods Duffel · balance sheet 455,490 €
- Pharmacie DE LA Tour Retail sale of pharmaceutical products Anderlues · balance sheet 490,336 €
Frequently asked questions about Ottimedi
What is the revenue of Ottimedi?
Ottimedi files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Ottimedi?
In Belgium, the VAT number is the company number prefixed with BE: BE0474978910 for Ottimedi, if the company is VAT-registered. Its company number (CBE) is 0474.978.910.
Where is the registered office of Ottimedi?
According to the CBE register, the registered office of Ottimedi is in 3052 Oud-Heverlee.
What is the equity of Ottimedi?
At the close of the 2025 financial year, the equity of Ottimedi amounts to 420,994 €, a solvency of 74.2% of total assets.
Who manages Ottimedi?
The register lists 2 active mandates at Ottimedi. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Ottimedi
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →